(Q42827027)

8 November 2017

title

Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapy (English)

1 reference

8 November 2017

1 reference

Céfai D

1

1 reference

8 November 2017

Schwaninger R

2

1 reference

8 November 2017

Balli M

3

1 reference

8 November 2017

Brunner T

4

1 reference

8 November 2017

Gimmi CD

5

1 reference

8 November 2017

publication date

1 July 2001

1 reference

Cell Death & Differentiation

8 November 2017

published in

1 reference

8 November 2017

volume

8

1 reference

8 November 2017

issue

7

1 reference

8 November 2017

page(s)

687-695

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4400862

8 November 2017

exact match

0 references

cites work

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Costimulation of T cells for tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Gene transfer of Fas ligand induces tumor regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Targeting HER-2/neu for active-specific immunotherapy in a mouse model of spontaneous breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Role of Fas ligand expression in promoting escape from immune rejection in a spontaneous tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

A modification of the JAM test is necessary for a correct determination of apoptosis induced by FasL+ adherent tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

The role of the Caspase family of cysteine proteases in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Regulation of the proinflammatory effects of Fas ligand (CD95L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Cutting Edge: The Tumor Counterattack Hypothesis Revisited: Colon Cancer Cells Do Not Induce T Cell Apoptosis Via the Fas (CD95, APO-1) Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

Escape from host-antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

7 January 2021

CD95 ligand expression as a mechanism of immune escape in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

7 January 2021

Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

7 January 2021

Fas counter-attack–the best form of tumor defense?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

7 January 2021

Antitumor effect of locally produced CD95 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

7 January 2021

The JAM test. A simple assay for DNA fragmentation and cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400862

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4400862

1 reference

Dimensions Publication ID

8 November 2017

1029886637

0 references

1 reference